Confluent reticulated papillomatosis wani abu ne da ba a saba gani ba amma na musamman da aka samu na ichthyosiform dermatosis wanda ke da duhu mai tsayi, ƙwanƙwasa, faci waɗanda galibi ana keɓe su akan gangar jikin tsakiya. Ana iya magance cutar ta Minocycline.
Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
Halin al'ada - Yana bayyana a matsayin baƙar fata mai launin launi ba tare da bayyanar cututtuka ba (ƙai, zafi) a kusa da kugu.
Confluent and reticulated papillomatosis (CRP) , wanda kuma ake kira ciwon Gougerot-Carteaud, yana haifar da haɓakar ƙwayoyin fata mara kyau. Yana bayyana a matsayin wuraren duhu marasa zafi waɗanda zasu iya haɗuwa cikin manyan faci, yawanci suna bayyana akan ƙirji na sama da wuyan matasa da matasa. Zaɓin magani na farko shine minocycline. Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
CRP yawanci yana bayyana azaman tabo masu duhu da faci ba tare da alamun bayyanar a kan fata a wuyansa, hannaye, ƙirji na sama, da babba na baya ba. Wani lokaci, yana iya bazuwa har zuwa goshi da ƙasa zuwa yankin ɗimbin jama'a. Magungunan rigakafi kamar minocycline sun zama zaɓin magani da aka fi so. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ maganin
#Minocycline